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Abstract
Background: In the context of the development of a successful malaria vaccine, understanding the
polymorphisms exhibited by malaria antigens in natural parasite populations is crucial for proper
vaccine design. Recent observations have indicated that sequence polymorphisms in the C-terminal
T-cell epitopes of the Plasmodium falciparum circumsporozoite protein (Pfcsp) are rather low and
apparently stable in low endemic areas. This study sought to assess the pattern in a malaria endemic
setting in Africa, using samples from Freetown, Sierra Leone.
Methods: Filter-paper blood samples were collected from subjects at a teaching hospital in
Freetown during September–October 2006 and in April–May 2007. The C-terminal portion of the
Pfcsp gene spanning the Th2R and Th3R epitopes was amplified and directly sequenced; sequences
were analysed with subject parameters and polymorphism patterns in Freetown were compared
to that in other malaria endemic areas.
Results and Discussion: Overall, the genetic diversity in Freetown was high. From a total of 99
sequences, 42 haplotypes were identified with at least three accounting for 44.4% (44/99): the 3D7-
type (19.2%), a novel type, P-01 (17.2%), and E12 (8.1%). Interestingly, all were unique to the
African sub-region and there appeared to be predilection for certain haplotypes to distribute in
certain age-groups: the 3D7 type was detected mainly in hospitalized children under 15 years of
age, while the P-01 type was common in adult antenatal females (Pearson Chi-square = 48.750,
degrees of freedom = 34, P = 0.049). In contrast, the single-haplotype predominance (proportion
> 50%) pattern previously identified in Asia was not detected in Freetown.
Conclusion: Haplotype distribution of the T-cell epitopes of Pfcsp in Freetown appeared to vary
with age in the study population, and the polymorphism patterns were similar to that observed in
neighbouring Gambia, but differed significantly at the sequence level from that observed in Asia.
The findings further emphasize the role of local factors in generating polymorphisms in the T-cell
epitopes of the P. falciparum circumsporozoite protein.
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Background
Every year malaria kills more than a million people world-
wide [1] and the need for an effective vaccine to boost
control efforts cannot be over-emphasized. In the context
of the development of a successful malaria vaccine, a
major potential obstacle is the issue of genetic polymor-
phisms exhibited by malaria antigens. While an under-
standing of these polymorphisms in natural plasmodium
populations is not only crucial for proper vaccine design,
deployment and evaluation, such data may also provide
invaluable insights into host-parasite interaction(s). The
Plasmodium falciparum circumsporozoite protein (Pf-CSP)
is the most abundant protein on the sporozoite's surface
and has a sequence comprising a central repeat that is
flanked by polymorphic N-terminal and C-terminal non-
repeat regions. The Pf-CSP antigen is the primary compo-
nent of the RTS,S [2], which is one of the leading malaria
vaccine candidates, and the only one to have shown mod-
erate, but promising, results during Phase II trials in adults
in The Gambia [3] and children in Mozambique [4]. Plans
for Phase III trials are currently underway in 10 African
nations [5]. Although field data on malaria antigen poly-
morphisms generally have been rather scanty, there is
now an improving trend partly due to increased training
of and collaboration with researchers in endemic nations.
With regards to the Pfcsp  gene, two distinct polymor-
phisms have been described: polymorphism in the
number of NANP repeats and single nucleotide polymor-
phisms (SNPs) in non-repeat regions. Although polymor-
phisms in the number of NANP repeats can be extensive
even in low endemic areas [6], it has been documented
that SNPs in the non-repeat regions (Th2R/Th3R
epitopes) in such settings, e.g. Southeast Asia, are stable
for an observation period of at least five years in Vietnam
[7], or 10 years in Thailand [8]. Moreover, the overall sce-
nario suggests that Asian parasites (with respect to the
Th2R/Th3R regions) are somewhat "clonal", with one
majority sequence predominating, probably reflecting
distinct differences between parasites from Asia (lower
endemicity) and Africa (higher endemicity). However,
samples examined from Africa at the population level
tended to be relatively small and with variation in sam-
pling time-points. These findings prompted the investiga-
tion of the diversity of Pfcsp  gene in a typical African
malaria-endemic setting in Sierra Leone. With no previous
data on this important topic in the country, the main aim
herein was to collect baseline sequence data and to char-
acterize sequence polymorphisms of the T-cell epitopes of
Pf-CSP among field isolates distributing in the capital,
Freetown, with an ultimate aim of acquiring insight into
host-parasite interaction(s). In addition, this study exam-
ined whether there was any significant difference in poly-
morphism patterns between African and Asian parasites.
Results confirmed marked sequence diversity of African
isolates as compared to Asia, with at least three major hap-
lotypes in Freetown. Moreover, haplotype distribution in
this endemic area appeared to vary with age, and presum-
ably immunity status. Implications of findings are dis-
cussed with regards to malaria vaccine design and local
malaria epidemiology.
Methods
Study area
This study was conducted at the Princess Christian Mater-
nity and Children's Hospital (PCMH), as part of a study
on G6PD deficiency polymorphisms, which has been
described in [9]. The PCMH is located in the East End of
Freetown, where it is surrounded by overcrowded residen-
tial and market areas. As the name implies, the hospital
not only plays a vital role in maternity medicine, but also
serves as one of the main national paediatric centers in the
country. Malaria transmission in Freetown is perennial
with apparent fluctuations in intensity during the rainy
(May–October) and dry (November–April) seasons.
Although there have been no recent malaria-related ento-
mologic studies in the capital, earlier studies have identi-
fied Anopheles gambiae, Anopheles funestus, Anopheles melas,
and Anopheles nili as efficient local malaria vectors, with P.
falciparum being the dominant parasite species (reviewed
in [10]). Previous research [10] also identified the capital
as fluctuating between that of a meso- and hyper-endemic
area, but studies are urgently required to properly assess
the current situation. Despite the long history of malaria
control activities in Sierra Leone, the disease is still a
major public health problem and accounts for about 40%
of outpatient consultations in the country. Presumptive
diagnosis followed by self-treatment is not uncommon,
and is thought to contribute greatly to the widespread
drug resistance recently documented in the country, war-
ranting a recent shift in national malaria treatment policy
[11].
Sample collection
Hospital-based surveys were conducted in mid-September
to mid-October 2006 and in mid-April to mid-May 2007.
Participants in this study comprised two main groups of
individuals residing in Freetown: (i) symptomatic chil-
dren visiting and/or admitted at the PCMH, as well as (ii)
antenatal out-patients visiting the PCMH microbiology
laboratory for routine blood tests (e.g. malaria micros-
copy, differential cell count, haemoglobin levels etc.).
Patients were introduced to the study and those consent-
ing were screened for malaria via microscopy, and filter
paper blood samples were collected for each subject. Filter
paper blood spots were air-dried, sealed in tiny plastic
bags and stored at room temperature (25–31°C), until
later molecular analysis at Jichi Medical University,
Tochigi, Japan. Prior to blood donation, subjects were
interviewed and basic demographic information for eachMalaria Journal 2009, 8:120 http://www.malariajournal.com/content/8/1/120
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participant were recorded including age, sex, ethnicity,
and whether they were admitted at the hospital (i.e. in-
patients) or only visiting (out-patients). Falciparum para-
sitaemia (parasite density) was determined for each sub-
ject by local microscopists, but due to technical
limitations encountered in the field parasite density data
was not utilized further.
DNA extraction and sequencing
Genomic DNA was extracted from randomly selected fil-
ter paper blood samples using the GFX kit (GE Healthcare,
UK), regardless of microscopy results. The C-terminal por-
tion spanning the T-cell epitope regions of the gene of P.
falciparum csp was amplified by a semi-nested PCR using
primers and cycle conditions described in [12]. In brief,
the first PCR used primers 5'-aatcaaggtaatggacaagg-3'
(CSo101) and 5'-ctaattaaggaacaagaagg-3 (CSo102); and 1
μl of the PCR product was used in a second round PCR
using primers CSo101 and a second reverse primer, 5'-
ggaacaagaaggataatacc-3' (CSo104) in a 20 μl reaction mix-
ture. Amplified gene fragments were resolved on 2% aga-
rose gels following electrophoresis and visualized by
ultraviolet (UV) light. The fragments of positive samples
were excised using FUNA Gel pipette tips (Funakoshi,
Tokyo, Japan), and diluted with 40–100 μl deionized dis-
tilled water depending on band intensity. Five microlitres
of diluted DNA was used as template for cycle sequencing
in a 10 μl reaction and the reverse primer was used to read
the sequences for each fragment on an ABI 310 Genetic
Analyzer. In principle, sequences were read once per sam-
ple using the second reverse primer (CSo104) but when a
new mutation was encountered or when two electropho-
regram peaks overlapped at a known mutation site,
sequencing was repeated with another independent sam-
ple using the forward primer (CSo101).
Sequence alignment and statistical analyses
Sequences were aligned using MEGA4 software [13] and
manually edited, with the sequence of the 7G8 strain from
Brazil [14] serving as reference. Each csp sequence was
treated as an independent entity, coded and statistical
analysis was conducted using the SPSS 10.0 software for
Windows. The 2-sided Pearson Chi-square test of inde-
pendence for categorical variables was used to compare
the respective frequencies of haplotypes with regards to
subject parameters including age, ethnicity, sex, and "sta-
tus" (i.e. whether hospitalized or not), as well as time of
sample collection. This was done in an attempt to exam-
ine the hypothesis whether haplotype distribution was
associated with age (and presumably immunity status) or
any of the other parameters described above. Statistical
significance was set at the 5% level (P = 0.05).
In an effort to examine geographical diversity patterns
with other parasite populations, the C-terminal portion of
recently published Pfcsp sequences from Vietnam [7] (n =
142), from Iran (n = 90) described in [15], and from one
cohort (n = 44) of field isolates from neighbouring Gam-
bia [16] were analysed. Commonly used intra-population
and inter-population genetic parameters were estimated
using DnaSP 4.5 software [17] and compared between
African (The Gambia and Sierra Leone) and Asian
sequences (Vietnam and Iran). Parameters investigated
include nucleotide diversity, pi (π) [18], which is the aver-
age number of substitutions between any two sequences,
and haplotype (gene) diversity values [18]. In addition,
the Wright's Fixation statistic (FST) [19], which measures
genetic differentiation between sub-populations, and
Nei's parameters [18] including the average number of
nucleotide differences per site (Dxy), net nucleotide sub-
stitution per site (Da), and average proportions of nucle-
otide substitutions per site (Kxy) between populations,
were also estimated.
This study was approved by the Ethical Committees of the
PCMH, University of Sierra Leone and Jichi Medical Uni-
versity, Tochigi, Japan, and the partial Pfcsp  sequences
obtained herein have been submitted to GenBank with
accession numbers GQ119637–GQ119678.
Results
Overview of data
Table 1 describes the demographic characteristics of all
study subjects in the PCMH 2006 study-group who pro-
vided blood samples, as well as the number of DNA sam-
ples successfully sequenced and analysed. For analytic
purposes, subjects from this PCMH 2006 study-group
were categorised into three main age groups: (i) below five
years of age, (ii) 5–14 years of age, and (iii) 15 years and
older. Of 164 filter paper blood samples, DNA was iso-
lated from 102 samples (i.e. isolates) of which 81 showed
bands (positive samples) following PCR amplification for
the target Pfcsp gene fragment of 321 base pairs (bp), and
Table 1: Summary characteristics of the PCMH 2006 study 
subjects (N = 164)
Age (in years) Number of subjects Totala
Sex Group Mean ± SD Inpatient Outpatient N (n)
Female <5 yr 2.1 ± 1.4 16 (4) 14 (5) 30 (9)
5–14 yr 8.5 ± 3.0 3 (1) 14 (3) 17 (4)
≥ 15 yr 25.6 ± 6.7 3 (0) 67 (18) 70 (18)
Subtotal 17.1 ± 11.9 22 (5) 95 (26) 117 (31)
Male <5 yr 1.8 ± 1.3 9 (7) 14 (14) 23 (21)
5–14 yr 8.5 ± 2.8 8 (6) 8 (8) 16 (14)
≥ 15 yr 26.5 ± 7.5 0 (0) 8 (6) 8 (6)
Subtotal 8.3 ± 9.5 17 (13) 30 (28) 47 (41)
a N represent the total number of blood sample donors and numbers 
in parentheses indicate subjects whose DNA samples were 
successfully sequenced and analyzed (n = 72)Malaria Journal 2009, 8:120 http://www.malariajournal.com/content/8/1/120
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these were successfully sequenced. Sixty-six sequences
were of clear electrophoregram peaks showing no or low
(<1/3) background overlap of the dominant peak. These
were referred to as "single dominant" sequences and
coded as "single-clone" infections. Six samples revealed
sequences with electrophoregram peaks overlapping at
one known mutation site for which both possible amino
acid sequences were deduced from the nucleotide
sequence (total n = 6 × 2). Nine samples showed chroma-
togram peak overlap at two or more known mutation sites
(termed "mixed-clone" infections), and were omitted in
the analysis presented here.
Among blood samples collected during the April–May
2007 survey, an additional set collected from the Thirty
Fourth Military Hospital (M-34) at Wilberforce (located
in the Western Area of Freetown, about 6 Km from the
PCMH) were also analysed. Of these 2007 samples, 12 of
47 (25.5%) from the PCMH and nine of 30 (30.0%) from
M-34 amplified and were sequenced, and all revealed
"single-dominant" sequences (Figure 1). There was a sig-
nificant difference (Chi-square = 3.84, degree of freedom,
d.f. = 1, P < 0.0001) in the number of PCR-positive sam-
ples between isolates collected in September–October
2006 i.e. during the rainy season (81/102 or 79.4%) and
in April–May 2007 i.e. the dry season (21/77 or 27.2%).
Haplotype distribution with age, sex and other parameters
Pooling the data and analysis of the whole set of 99 C-ter-
minal csp sequences (including the six double-clone infec-
tions) from Freetown identified a total of 42 unique
haplotypes for which the respective proportions are
depicted in Figure 1. Three major haplotypes were
detected: the 3D7-type (19.2%) which is identical to the
RTS,S vaccine sequence, a previously undescribed haplo-
type, P-01 (17.2%), and E-12 (8.1%) a sequence that has
been reported from neighbouring Gambia. A majority of
the remaining haplotypes comprised mostly minority
alleles and almost all were unique to the West African sub-
region at the nucleotide level. Consistent with previous
studies, almost all mutations observed (except for haplo-
type P-17) were non-synonymous, and clustered in the T-
cell epitope regions (Th2R, Th3R) of the gene, although a
few sequences had mutations in the region preceding the
Th2R (labeled X in Figure 1). Moreover, there was an Arg
> Gly substitution (haplotype P-10 in Figure 1) in the
highly conserved region II i.e. a region sandwiched
between the Th2R and Th3R, which has been implicated
in hepatocyte binding [20]. Interestingly, most of the
observed haplotypes usually differed from one another by
one non-silent point mutation in the whole C-terminal
region. For example, the P-10 haplotype differed from the
3D7 sequence only by the amino residue substitution at
position 360 in Figure 1, while the P-01 isolate that dom-
inated in antenatal out-patients differed from the P-30
isolate only by the R>T substitution at residue position
337. Haplotypes E12 and Cam3006 differed by one muta-
tion in Th2R, whereas 3D7 and P-03 differed by a muta-
tion in the Th3R. A similar trend was observed for other
haplotypes, tempting the speculation that some form of
recombination events might be occurring in these C-ter-
minal T-cell epitope regions of CSP in natural parasite
populations.
Preliminary analysis for the whole set of 99 sequences
revealed a non-significant (Pearson Chi-square value of
93.219, degrees of freedom = 82, P = 0.187), yet unex-
pected haplotype distribution pattern with respect to age.
As shown in Figure 2, the 3D7 and a previously unde-
scribed haplotype (P-01) appeared to predominate in dif-
ferent age groups, in which the former was associated with
mainly children under 15 years and the latter with adult
women. Subsequent sub-group analysis of the 2006
PCMH data (using all sequences including single as well
as the six double-clone infections) by age, sex, ethnicity
and patient status (i.e. in-patient or out-patient) revealed
a significant, albeit weak, association only for the out-
patient females (Pearson Chi-square value of 48.750, d.f.
= 34, P = 0.049), who were mainly pregnant women visit-
ing for regular antenatal follow-up. However, repeating
the analysis with one sequence per isolate (i.e. using a ran-
domly selected sequence from the six double-clone
infected samples) reduced the p-value slightly (Pearson
Chi-square value of 46.944, d.f. 32, P = 0.043). The avail-
ability of fewer sequences in other sub-groups precluded
further comprehensive analysis with respect to sampling
time and place. Nonetheless, it appears that, in this Afri-
can endemic setting, haplotype frequencies are likely to
vary with time (e.g. season), as demonstrated between
samples collected in 2006 (rainy season) and 2007 (dry
season) in Figure 1, as well as by the proportion of PCR-
positive samples in 2006 i.e. 79.4% (81/102) versus
27.3% (21/77) in 2007.
Geographical distribution of csp haplotypes
Spatial polymorphism patterns were examined by com-
paring recently published sympatric (of parasites from the
same locality at a given time) csp sequences obtained from
hospital-based surveys in different countries [7,15,16].
These data were acquired through direct sequencing of
isolates, allowing appropriate comparison to data pre-
sented here, and only the region (207 bp) spanning the
Th2R and Th3R epitopes was used (i.e. spanning amino
acid positions 326 – 394). Of 375 sequences 126 (33.6%)
were of the predominant haplotype i.e. the Th2R*5/
Th3R*1 [7,15,16] unique to Asia (Vietnam: 75/142 or
52.8% and Iran: 51/90 or 56.7%), but was not found in
The Gambia nor in Sierra Leone (Additional File 1). Sim-
ilarly, other common haplotypes in West Africa (3D7, P-
01, E12) were not detected in Vietnam or in Iran, whileMalaria Journal 2009, 8:120 http://www.malariajournal.com/content/8/1/120
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Sequences of P. falciparum csp haplotypes found among field isolates from two hospitals (PCMH and M-34) in Freetown, Sierra  Leone, during September–October 2006 and April–May 2007 Figure 1
Sequences of P. falciparum csp haplotypes found among field isolates from two hospitals (PCMH and M-34) in 
Freetown, Sierra Leone, during September–October 2006 and April–May 2007. Note that only variable sites imme-
diately after the central repeats (labeled X i.e. amino residues 308 – 317), and the regions spanning the Th2R (amino residues 
326 – 342) and Th3R (amino residues 356 – 378) in the C-terminal portion of the gene are shown. Amino residue numbering 
is with reference to the 7G8 sequence and haplotypes labeled P-01 ~ P-30 are unique to this study. The P-17 haplotype differs 
from the 3D7 sequence by two silent nucleotide mutations but otherwise has an identical amino acid sequence. As shown, the 
"Asia-type*" refers to the Th2R*5/Th3R*1 haplotype previously shown to be predominant in Asia, but was not detected in this 
study.
X Th2R epitope Th3R epitope
Haplotype 308 - 317 326 - 342 356 - 378 PCMH PCMH M-34 Total
7G8 VDENANANNA PSDKHIEQYLKKIKNSI GIQVRIKPGSANKPKDELDYEND 2006 2007 2007 Count
Asia-type* .......... .............Q..L ....................... 0
3D7 ........S. ......KE..N..Q..L ....................A.. 18 1 19
B01/7G8 .......... ................. ....................... 213
Cam1001 .N........ .......K...E.Q..L ...........G...N....... 11
Cam1028 .......... ...Q...K...T....L ................Q...A.. 22
Cam1051 .......... ...Q...K..N.....L ................Q...A.. 11
Cam1052 ..K....... .......E......... ....................... 11
Cam1062 .......... ...Q...K...R.Q..L ................Q...A.. 21 3
Cam3006 .......... ...Q...K...I....L ................Q...A.. 31 4
E08 .......... ...........T....L ..................N.... 11
E12 .......... ...Q...K...I.Q..L ................Q...A.. 521 8
G04 .......... ......TE.....Q..L ...........G.S.N....... 11
G06 .......... ...Q...K..Q..Q..L ................Q...A.. 11
P-01 .......... ...........R.Q..L ....................A.. 17 17
P-02 .......... ...Q...K..N.....L ........D.......Q...A.. 33
P-03 ........S. ......KE..N..Q..L ....................... 33
P-04 ......G... ...Q...K...I.Q..L ................Q...A.. 22
P-05 ........S. ......KE..N..Q..L ................Q...A.. 22
P-06 .......... ......KE...I.Q..L ...........G...E..N.... 22
P-07 .......... ...Q...K..Q..Q..L ................Q.N.... 22
P-08 .......... ...Q...K...T.Q..L ................Q...... 11
P-09 .......... ......K......Q..L ....................A.. 11
P-10 ........S. ......KE..N..Q..L ....G...............A.. 11
P-11 .......... .......E...R.Q..L ....................A.. 11
P-12 .......... ...Q...K...T....L ...........G.S......... 11
P-13 .......... ...Q...K..Q.....L ................Q.N.... 11
P-14 .......... ...........T....L ...............E....... 11
P-15 .......... ...Q...K......... ....................... 11
P-16 ........S. ......K...N..Q..L ....................A.. 11
P-17 ........S. ......KE..N..Q..L ....................A.. 11
P-18 .......... ...Q...K..N...... ................Q...A.. 11
P-19 .......... ...Q...K...R.Q..L ....................A.. 11
P-20 .......... ...Q...K..QI.Q..L ................Q...A.. 11
P-21 ........S. ......KE..N..R..L ....................A.. 11
P-22 ........S. ....R.KE..N..Q..L ....................A.. 11
P-23 .......... ......KE..N..Q..L ....................A.. 11
P-24 .......... ......K....R.Q..L ....................A.. 11
P-25 .......... ...Q...E...R.Q..L ................Q...A.. 11
P-26 .......... ......NK...R.Q..L ....................A.. 11
P-27 .......... ...Q...E..N..Q... ....................A.. 11
P-28 .......... ...Q...E.....Q... ....................A.. 11
P-29 .......... ...........I.R..L ...........D....Q...A.. 11
P-30 .......... ...........T.Q..L ....................A.. 11
Total 78 12 9 99
Amino acid sequence
Malaria Journal 2009, 8:120 http://www.malariajournal.com/content/8/1/120
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the 7G8 sequence was found in all three countries except
Vietnam. While this differential csp-haplotype distribu-
tion was statistically significant by Chi-square analysis
using SPSS (Pearson Chi-square = 766.847, d.f. = 219, P <
0.00001), it is of interest to note that not finding a partic-
ular haplotype does not completely preclude its existence
in the locality of interest but may simply suggest it might
be of low frequency. Another striking feature was that all
mutations were almost always restricted to the same posi-
tions in the T-cell epitope regions of the gene, regardless
of parasite origin. What seemed important was the nature
of the substituting amino acid, again suggesting strong
functional constraints on the CSP molecule.
As depicted in Table 2, within-population genetic diver-
sity estimates (π, haplotype diversity) reveal consistent
patterns in all countries, with the Th2R epitope region
being more polymorphic than the Th3R region. However,
between-population genetic differentiation parameters
(FST, Dxy, Kxy and Da) indicate regional differences, with
African parasites having similar indices than they are to
Asian parasites. This data is probably reminiscent of dif-
ferences in transmission intensities/dynamics between
the respective geographic regions.
Discussion
Presented here is the first malaria molecular epidemio-
logic study in Sierra Leone on the genetic diversity of T-cell
epitope regions in the C-terminal portion of the P. falci-
parum circumsporozoite protein among wild isolates cir-
culating in the capital, Freetown. Contrary to previous
data presented from moderate to low endemic settings of
malaria [6-8,15], results of this study indicate that
sequence polymorphisms in the same region of Pfcsp
(Th2R/Th3R epitopes) in an African setting are markedly
diverse, but again with some degree of restriction. In addi-
tion, the single-haplotype predominance of the "Asia
type" sequence (proportion > 50%) previously docu-
Distribution of csp haplotypes by age category among the PCMH 2006 sequences for which n = 33, 21, and 24 for the 3 respec- tive age groups Figure 2
Distribution of csp haplotypes by age category among the PCMH 2006 sequences for which n = 33, 21, and 24 
for the 3 respective age groups: (i) less than 5 years (black bars) of age (ii) between 5 and 14 years (grey bars) and (iii) 15 
years or older (open bars). Note that all sequences from single-clone as well as the six double-clone infections were used in 
this analysis. The 3D7 haplotype was found more in children aged less than 15 years while the P-01 allele was more prevalent 
in adult females, who were mostly antenatal follow-up subjects.
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mented in Asia (Additional file 1) was not observed in this
African setting. Instead three haplotypes accounted for the
majority (44.4%) of the sequences i.e. 3D7 (19.2%), P-01
(17.2%) and E12 (8.1%), and with intriguing distribution
patterns. The 3D7 allele was associated with hospitalized
children in two age groups (<5 years of age and 5–15 years
of age), but not with adults, while another previously
undescribed haplotype (P-01) was significantly associated
with visiting antenatal subjects (P = 0.049). Since most of
these antenatal females were of mild or asymptomatic
infection, this finding inevitably warrants the speculation
whether distribution of P. falciparum csp haplotypes could
be associated with disease severity i.e. does naturally-
acquired immunity select for certain CSP variants in
malaria-endemic areas? While the data presented here
may in part support this notion, it may also be argued that
this study may have suffered due to limited sample size
(thus underpowered), or the findings may have been sim-
ply due to chance (borderline P values). Whatever the
case, this haplotype distribution pattern in an African
endemic area is important in that it adds insight into a rel-
evant issue in vaccine design and evaluation i.e. could
there indeed be significant differences of vaccine effects in
symptomatic versus asymptomatic malaria individuals, par-
ticularly in the context of an African endemic setting
where transmission is usually intense? This might be a
major issue for consideration in future large-scale longitu-
dinal studies on malaria antigen polymorphisms of vac-
cine antigens in other endemic nations.
Despite the documented polymorphisms in CSP, the
mechanism(s) behind them are poorly understood. Pro-
posed mechanisms include intragenic recombination and
natural selection (human immune pressure- or mosquito-
induced). In recent field trials of the most advanced CSP
vaccine (RTS,S), it was demonstrated that vaccine-medi-
ated immunity was not strain-specific [21], nor did the
vaccine induce T-cell epitope selection [12]. A subsequent
study using samples from Thailand further questioned the
contribution of human immune pressure towards epitope
diversity in the csp [8]. Thus it was suggested that this sce-
nario could be due to a major contributory role of "mos-
quito-induced" selection by the different vector species
transmitting malaria in the different geographic regions
[8,15]. However, it appears that this "mosquito-induced"
selection may not completely explain the observed differ-
ential haplotype distribution patterns in different
endemic settings, as documented in this study. Moreover,
although one study recently demonstrated that sterile pro-
tection is independent of the circumsporozoite protein
[22], the role of the human immune system is supported
by other studies documenting induced immune responses
to CSP [23-26]. Taken together, the data suggest that the
role of the human host's immune pressure cannot be
completely excluded, even if it potentially leads to a non-
protective or partially protective immune response, as
might be expected in an immune-evasion strategy.
Thus, a more likely explanation would incorporate a com-
plex interplay of a combination of factors including host-
immune selection (presumably due to differential bind-
Table 2: Intra-population genetic diversity and inter-population genetic differentiation estimates of Asian and African parasites
(a) Intra-population genetic diversity parametersa
No. of No. of Haplotype Nucleotide diversity per site (π)
Population sequences haplotypes diversity Th2R Th3R All sites
Gambia 44 21 0.95137 0.07526 0.04343 0.02882
Sierra Leone 99 40 0.91899 0.06753 0.02926 0.02366
Vietnam 142 20 0.69693 0.02625 0.01420 0.00983
Iran 90 5 0.60275 0.01530 0.00632 0.00530
(b) Inter-population genetic differentiation parameters
Population-1 Population-2 FST
b Dxyc Dad Kxye
Gambia Sierra Leone 0.04403 0.02745 0.00121 5.68205
Gambia Vietnam 0.24410 0.02557 0.00624 5.29209
Gambia Iran 0.27967 0.02366 0.00662 4.89798
Sierra Leone Vietnam 0.31434 0.02442 0.00768 5.05499
Sierra Leone Iran 0.37256 0.02305 0.00859 4.77149
Vietnam Iran 0.13221 0.00870 0.00115 1.80031
aEstimates are based on pair wise analyses of 375 sequences of the C-terminal portion (207 bp) of the CSP gene spanning the Th2R and Th3R using 
DnaSP4.5 (21)
bFST: Wright's Fixation index, which is a measure of genetic differentiation between populations (range from 0 to +1)
cDxy: measures the average number of nucleotide differences per site between populations
dDa: measures the number of net nucleotide substitutions per site between populations
eKxy: measures the average proportions of nucleotide substitutions per site between populationsMalaria Journal 2009, 8:120 http://www.malariajournal.com/content/8/1/120
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ing of parasite-derived peptides to host molecules), trans-
mission dynamics, strong functional constraints on the
protein, as well as the reproductive nature of the parasite.
Which factor(s) contribute a major role at any given time
and place would depend largely on a "net effect" given the
local epidemiologic situation. Generally, regions of high
P. falciparum transmission intensity correlate with high
parasite prevalence and high genetic diversity of the para-
site, with resultant high proportion of mixed genotypes in
a given infection. This would increase the probability that
a feeding mosquito obtains genetically distinct haplo-
types in its blood meal, which in turn increases the prob-
ability of out-crossing in the midgut. This is consistent
with data presented here considering the numerous CSP
haplotypes circulating in this African endemic setting, as
well as the tendency for sympatric parasites appearing to
be more closely related than their allopatric counterparts
(Figure 1, Table 2). In low transmission areas, it is
expected that the low genetic diversity would limit the
observed recombination events as detected by common
algorithms, with the tendency of having a somewhat
"clonal" population pattern in such low transmission
areas. The finding of a predominant haplotype using
larger samples in Asia e.g. the "Asia-type" (Additional file
1) and, more recently, the predominance of the 7G8 hap-
lotype in Peru [27] would support this scenario. In short,
it may be necessary to reflect these epidemiologic differ-
ences while interpreting field data on csp or other malaria
antigen polymorphisms.
Hopefully future large-scale studies on Pfcsp  polymor-
phism, supplemented with well-coordinated entomologic
and sero-immunological analyses, in other African
endemic areas would shed more light on this issue, simi-
lar to what was recently documented for the P. falciparum
merozoite surface protein-1 (MSP-1) in Mali [28].
Conclusion
This study highlights an apparent discordant haplotype
distribution of the T-cell epitopes of Pf-CSP with respect
to age. In addition, the observed sequence polymorphism
patterns were similar to that in neighbouring Gambia, but
differed significantly at the sequence level from that
observed in Asia. Thus, the interpretation of genetic diver-
sity data of malaria antigen genes should probably reflect
not only the antigen but also the local epidemiologic sit-
uation. In the context of the RTS,S vaccine, its future
deployment in Sierra Leone is envisioned to confer similar
protection in children based on extrapolation of efficacy
results from The Gambia and Mozambique, because the
3D7 haplotype appears to be prevalent in this endemic
setting.
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